Lusaris Therapeutics
Drug Discovery
Lusaris Therapeutics valuation and funding history | Last updated: October 13, 2022 | 1 funding rounds
Current Valuation
N/A
As of October 13, 2022
Total Funding Raised
N/A
Across 1 round
Last Round
Early Stage VC (Series A)
$60.2M
Last Funding
Oct 2022
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| October 13, 2022 | Early Stage VC (Series A) | $60.2M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Lusaris Therapeutics is currently valued at N/A as of October 13, 2022.
What is Lusaris Therapeutics Worth in 2026?
Lusaris Therapeutics is a leading private company in the Drug Discovery sector. Track Lusaris Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Lusaris Therapeutics Valuation is Determined
Private company valuations like Lusaris Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.